Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur J Immunol. 1997 Aug;27(8):2043-7.

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.

Author information

1
Unité d'Immunologie et d'Hématologie, Hôpital Necker-Enfants Malades, Paris, France.

Abstract

Recently, an inherited syndrome characterized by nonmalignant lymphoproliferation with autoimmune manifestations, caused by mutations of the Fas (CD95) receptor gene has been described. Because of disease severity, i.e. unremitting lymphoproliferation in a child with complete Fas deficiency, a haploidentical bone marrow transplantation (BMT) was performed despite the known resistance of Fas-deficient lpr mice to bone marrow transplantation. Marrow graft was rejected early; however, a second attempt using bone marrow from the mother led to engraftment and to control of lymphoproliferation and of autoimmune thrombocytopenia up to the last follow-up at 24 months after BMT. This single case shows that resistance to bone marrow engraftment caused by survival of Fas-deficient cells can be overcome.

PMID:
9295043
DOI:
10.1002/eji.1830270831
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center